Application
Benchling & Jounce Therapeutics: Migrating to an All-in-One Cloud Solution Saves Time on Data Management
Benchling
Aug 24, 2021
Abstract
Jounce Therapeutics uses a number of different analytical techniques to identify biomarkers in the tumor microenvironment (TME) that can help them match their drug candidates with the right patients. But they needed a way to manage all their assay and antibody data from concept to IND across different teams. Learn how Benchling unified Jounce's digital infrastructure to improve productivity and collaboration, and achieve a 100% software adoption rate.
Application File
Benchling & Jounce Case Study.pdf
Comments
Be the first to comment.